login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GT BIOPHARMA INC (GTBP) Stock News
USA
- NASDAQ:GTBP -
US36254L3087
-
Common Stock
0.5971
USD
-0.07 (-10.45%)
Last: 10/29/2025, 8:00:01 PM
0.5964
USD
0 (-0.12%)
Pre-Market:
10/30/2025, 8:21:06 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GTBP Latest News, Press Relases and Analysis
All
Press Releases
21 days ago - By: Chartmill
- Mentions:
HELE
MSN
AMBO
CABA
...
These stocks are moving in today's session
21 days ago - By: Benzinga
- Mentions:
XTLB
NXL
PCSA
UPC
...
12 Health Care Stocks Moving In Thursday's Intraday Session
21 days ago - By: Benzinga
- Mentions:
PBM
ADAP
NXL
PCSA
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
21 days ago - By: Stocktwits
GT Biopharma Stock Logs Best Session In Over 9 Months On Promising Cancer Trial Data; Retail Eyes Double-Digit Rally
22 days ago - By: GT Biopharma, Inc.
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
24 days ago - By: GT Biopharma, Inc.
GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit
3 months ago - By: GT Biopharma, Inc.
GT Biopharma Reports Second Quarter 2025 Financial Results
3 months ago - By: GT Biopharma, Inc.
GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2
5 months ago - By: GT Biopharma, Inc.
GT Biopharma Appoints New Member to its Board of Directors
Please enable JavaScript to continue using this application.